Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Balk

Showing results (41-50 of 189) with videos related to

Pageof 19
Sort By:
Molecular Endocrinology (Baltimore, Md.)|June 29, 2002
Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressorShinta Cheng, Sabrina Brzostek, Suzanne R Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2005
CD1d ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12Simon C Yue, Angela Shaulov, Ruojie Wang, et al.
The Journal of Biological Chemistry|May 17, 2002
Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptorDavid Masiello, Shinta Cheng, Glenn J Bubley, et al.
Plos One|July 31, 2012
Doxycycline regulated induction of AKT in murine prostate drives proliferation independently of p27 cyclin dependent kinase inhibitor downregulationHongyun Wang, Youyuan Xu, Zi Fang, et al.
Elife|June 3, 2020
MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activationSeiji Arai, Andreas Varkaris, Mannan Nouri, et al.
Cancer Treatment Reviews|October 22, 2013
Castration-resistant prostate cancer: adaptive responses in the androgen axisAlison Egan, Yan Dong, Haitao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer ApoptosisSeiji Arai, Oliver Jonas, Matthew A Whitman, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2011
Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defectsMark A Exley, Lydia Lynch, Bindu Varghese, et al.
Cancer Research|June 4, 2009
Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2Changmeng Cai, David C Portnoy, Hongyun Wang, et al.
The Journal of Biological Chemistry|June 12, 2003
A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4Avital L Amir, Moumita Barua, Nicole C McKnight, et al.
Pageof 19

Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
Molecular Endocrinology (Baltimore, Md.)|June 29, 2002
Inhibition of the dihydrotestosterone-activated androgen receptor by nuclear receptor corepressorShinta Cheng, Sabrina Brzostek, Suzanne R Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2005
CD1d ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12Simon C Yue, Angela Shaulov, Ruojie Wang, et al.
The Journal of Biological Chemistry|May 17, 2002
Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptorDavid Masiello, Shinta Cheng, Glenn J Bubley, et al.
Plos One|July 31, 2012
Doxycycline regulated induction of AKT in murine prostate drives proliferation independently of p27 cyclin dependent kinase inhibitor downregulationHongyun Wang, Youyuan Xu, Zi Fang, et al.
Elife|June 3, 2020
MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activationSeiji Arai, Andreas Varkaris, Mannan Nouri, et al.
Cancer Treatment Reviews|October 22, 2013
Castration-resistant prostate cancer: adaptive responses in the androgen axisAlison Egan, Yan Dong, Haitao Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2018
Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer ApoptosisSeiji Arai, Oliver Jonas, Matthew A Whitman, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2011
Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defectsMark A Exley, Lydia Lynch, Bindu Varghese, et al.
Cancer Research|June 4, 2009
Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2Changmeng Cai, David C Portnoy, Hongyun Wang, et al.
The Journal of Biological Chemistry|June 12, 2003
A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4Avital L Amir, Moumita Barua, Nicole C McKnight, et al.
Pageof 19